The hypothesis underlying this Program Project is that cell free hemoglobin, suitably modified by structural engineering, will be safe and effective therapy in many clinical situations where red blood cells are indicated. The main goal of the Program Project is to understand the physiological consequences and clinical potential of replacement of red blood cells in the circulation with acellular blood substitutes. Expertise in design, production and testing of new solutions, with academic expertise in several key areas of biochemistry, physiology, molecular biology and clinical medicine will be brought together under this Program Project to focus on specific problems of large scale infusions of acellular red cell substitutes, while simultaneously exploiting emerging technology to shed new light on basic physiological and biochemical problems. The elements of the Program Project reflect the interests of the UCSD faculty, rather than a comprehensive approach to development of blood substitutes. However, the expertise is broad and deep, and nearly all relevant areas will be studied. Core A will coordinate activities of the component projects and cores, manage budget, purchasing, scheduling of meetings and seminars, and provide basic secretarial support. Core B will produce or obtain materials representing various classes of products under development for investigation by the various projects, including both hemoglobin- and perflurocarbon-based oxygen carries; some will be produced in the Program Project, and others will be obtained from other laboratories. The in vitro ligand binding, stability and toxicity will be related to protein structure in Project 1, and the effects on the microcirculation will be studied in Project 2, the heart in Project 3, the kidney in Project 4. Data obtained in these projects will be used in Project 1 for the design of new chemically modified or (by collaboration) mutant derivatives of hemoglobin using computer visualization techniques in Project 1. Each project will have advisors from the UCSD faculty. An executive committee made up of the principal investigators from each project and core that has met monthly for the last year will form the nucleus of a group and will continue to share data, results, and plans for future studies. Internal and external advisory groups of outstanding scientists will be appointed to provide expertise in related fields.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL048018-03
Application #
2224062
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1993-09-01
Project End
1998-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Kotlovyi, Vladimir; Nichols, William Lee; Ten Eyck, Lynn F (2003) Protein structural alignment for detection of maximally conserved regions. Biophys Chem 105:595-608
Schwartz, D; Schwartz, I F; Blantz, R C (2001) An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. J Lab Clin Med 137:107-14
McCarthy, M R; Vandegriff, K D; Winslow, R M (2001) The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 92:103-17
Winslow, R M (2000) alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang 79:20-Jan
Chen, W; Dumoulin, A; Li, X et al. (2000) Transposing sequences between fetal and adult hemoglobins indicates which subunits and regulatory molecule interfaces are functionally related. Biochemistry 39:3774-81
Sakai, H; Hara, H; Tsai, A G et al. (2000) Constriction of resistance arteries determines l-NAME-induced hypertension in a conscious hamster model. Microvasc Res 60:21-7
Sakai, H; Hara, H; Yuasa, M et al. (2000) Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279:H908-15
Sakai, H; Hara, H; Tsai, A G et al. (1999) Changes in resistance vessels during hemorrhagic shock and resuscitation in conscious hamster model. Am J Physiol 276:H563-71
Erni, D; Sakai, H; Tsai, A G et al. (1999) Haemodynamics and oxygen tension in the microcirculation of ischaemic skin flaps after neural blockade and haemodilution. Br J Plast Surg 52:565-72
Schwartz, D; Blantz, R C (1999) Nitric oxide, sepsis, and the kidney. Semin Nephrol 19:272-6

Showing the most recent 10 out of 59 publications